Skip to main content
Premium Trial:

Request an Annual Quote

Joshua Boger, Craig Burson, John Igoe, Richard Brandywie, Jack Rybicki, Louis TM Conti, Wayne Hunter, Paul Andre, Lisa Kobialka

Premium

Massachusetts High Tech Council Names Biotech President/CEO as New Chairman
 
Joshua Boger, the president and CEO of Vertex Pharmaceuticals, has been named board chairman of the Massachusetts High Technology Council, which represents the state’s life sciences, defense technology and other tech-based industries.
 
Boger founded Vertex, the Cambridge, Mass.-based small-molecule biotech giant, in 1989. He is also chairman of BIO, the biotechnology industry's national trade organization. 
 
From 1997 to 2006, Boger additionally served as Vertex’s chairman. Before launching Vertex, Boger was senior director of basic chemistry at Merck Sharp & Dohme Research Laboratories. Boger began his industry career at Merck in 1978.
 
Boger holds a BA degree in chemistry and philosophy from Wesleyan, and MSci and PhD degrees in chemistry from Harvard University.
 

 
Florida Venture Forum Elects Officers for 2008 Term
 
The Florida Venture Forum board of directors recently elected officers for its 2008 term:
  • Craig Burson, managing director with HIG Ventures of Miami, will serve as board chair.
  • John Igoe, partner with Edwards Angell Palmer & Dodge of West Palm Beach, Fla., vice chair.
  • Richard Brandewie, managing partner and co-founder of Ballast Point Ventures of St. Petersburg, Fla., program chair.
  • Jack Rybicki, principal with LarsonAllen, of Tampa, Fla., treasurer.
  • Louis TM Conti, partner with Holland & Knight of Orlando; and Wayne Hunter, managing partner with Harbert Venture Partners of Richmond, Va., conference co-chairs for the venture forum’s 2009 Florida Venture Capital Conference, to be held Feb. 3-4, 2009, at the Naples (Fla.) Grande Resort. Hunter served as conference co-chair for the 2008 Florida Venture Capital Conference, held earlier this month.
The venture forum is a statewide group for venture capitalists and entrepreneurs created in 1984.
 

 
International Law Firm Adds Two Partners In California Expansion
 
International law firm King & Spalding has hired two partners from the Menlo Park, Calif., office of Perkins Coie for its new Silicon Valley office in Redwood shores (see Around the Regions, this issue). Both will specialize in intellectual property and high-technology litigation:
  • Paul Andre has represented clients on issues including biotechnology, medical devices, software and computer hardware. He received a JD degree from Fordham University School of Law, an MSci degree in Immunology and BSci degree in biology/physics from Middle Tennessee State University, and he was a PhD candidate in cellular and molecular biology at the Mount Sinai School of Medicine.
  • Lisa Kobialka, the former head of Perkins Coie's Menlo Park commercial litigation practice, has handled commercial litigation matters. She earned a JD degree at the University of San Francisco Law School, an MM degree at the San Francisco Conservatory of Music and a BA degree at the University of California, Davis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.